EUVIMEDEUVIMED entdecken
Crossref

Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway

Panpan Wei, Kangli Tian, Haole Liu, Kexin Li, Naqash Alam, Daxin Cheng, Meng Li, Xue He, Jia Guo, Rong Wang, Weirong Wang, Liang Bai und 4 weitere

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024

DOI: 10.1016/j.bbadis.2024.167170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024. Verfasst von Panpan Wei und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Science, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Cell Proliferation, Hyperplasia, Mice, Knockout. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Xi’an Jiaotong University, Shaanxi Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intimal hyperplasia (IH) is a common pathological feature of vascular proliferative diseases, such as atherosclerosis and restenosis after angioplasty. Urotensin II (UII) and its receptor (UTR) are widely expressed in cardiovascular tissues. However, it remains unclear whether the UII/UTR system is involved in IH. Right unilateral common carotid artery ligation was performed and maintained for 21 days to induce IH in UTR knockout (UTR-/-) and wild-type (WT) mice. Histological analysis revealed that compared with WT mice, UTR-deficient mice exhibited a decreased neointimal area, angiostenosis and intima-media ratio. Immunostaining revealed fewer smooth muscle cells (SMCs), endothelial cells and macrophages in the lesions of UTR-/- mice than in those of WT mice. Protein interaction analysis suggested that the UTR may affect cell proliferation by regulating YAP and its downstream target genes. In vitro experiments revealed that UII can promote the proliferation and migration of SMCs, and western blotting also revealed that UII increased the protein expression of RhoA, CTGF, Cyclin D1 and PCNA and downregulated p-YAP protein expression, while these effects could be partly reversed by urantide. To evaluate the translational value of UTRs in IH management, WT mice were also treated with two doses of urantide, a UTR antagonist, to confirm the benefit of UTR blockade in IH progression. A high dose of urantide (600 μg/kg/day), rather than a low dose (60 μg/kg/day), successfully improved ligation-induced IH compared with that in mice receiving vehicle. The results of the present study suggested that the UII/UTR system may regulate IH partly through the RhoA-YAP signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingCell ProliferationHyperplasiaMice, KnockoutReceptors, G-Protein-CoupledrhoA GTP-Binding ProteinSignal TransductionYAP-Signaling ProteinsAnimalsMaleMiceCell Cycle ProteinsCell MovementLigationMice, Inbred C57BLMuscle, Smooth, VascularMyocytes, Smooth MuscleNeointimaTunica IntimaUrotensins

Stichwörter der Autor:innen

Intimal hyperplasiaRhoAUrantideUrotensin II receptorYAP

Substanzen

Adaptor Proteins, Signal TransducingCell Cycle ProteinsReceptors, G-Protein-CoupledrhoA GTP-Binding ProteinRhoA protein, mouseurotensin IIUrotensinsYAP-Signaling ProteinsYap1 protein, mouseurotensin II receptor, mouse

Autor:innen und Institutionen

  • Institute of Cardiovascular Science, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
  • Laboratory Animal Center, Xi'an Jiaotong University, Xi'an 710061, China.
  • Department of Vascular Surgery, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Institute of Cardiovascular Science, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China; Laboratory Animal Center, Xi'an Jiaotong University, Xi'an 710061, China.
  • Institute of Cardiovascular Science, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China; Laboratory Animal Center, Xi'an Jiaotong University, Xi'an 710061, China. Elec…

Förderung

  • Xi’an Jiaotong University
  • Shaanxi Province Natural Science Foundation

Zitieren

APA

Wei, P., Tian, K., Liu, H., Li, K., Alam, N., Cheng, D., Li, M., He, X., Guo, J., Wang, R., Wang, W., Bai, L., Liu, E., Xu, B., Li, Y., & Zhao, S. (2024). Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167170

Vancouver

Wei P, Tian K, Liu H, Li K, Alam N, Cheng D, et al. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. doi:10.1016/j.bbadis.2024.167170

BibTeX
@article{Wei2024,
  author = {Wei, Panpan and Tian, Kangli and Liu, Haole and Li, Kexin and Alam, Naqash and Cheng, Daxin and Li, Meng and He, Xue and Guo, Jia and Wang, Rong and Wang, Weirong and Bai, Liang and Liu, Enqi and Xu, Baohui and Li, Yankui and Zhao, Sihai},
  title = {Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2024},
  doi = {10.1016/j.bbadis.2024.167170}
}
Kostenlos starten →